Cancer Research UK logo.
SearchDonate
  • Search

A trial of electrocautery ablation to prevent lung cancer (EARL)

Overview

Cancer types:

Lung cancer

Status:

Closed

Phase:

Phase 2/3

Details

This trial is looking at treating areas of abnormal cells in the lungs with an electric current (electrocautery) to prevent lung cancer.

Cancer Research UK supports this trial.

Recruitment start: 29 October 2020

Recruitment end: 6 October 2022

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Sam Janes

Supported by

Cancer Research UK

University College London (UCL)

Other information

This Cancer Research UK trial number is CRUK/15/077.

Last reviewed: 28 Dec 2022

CRUK internal database number: 13909

Help and support